Related Experiment Video

Updated: Aug 20, 2026

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
12:49

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation

Published on: March 21, 2020

RING finger ubiquitin-protein isopeptide ligase Nrdp1/FLRF regulates parkin stability and activity

Ling Zhong1, Ying Tan, An Zhou

  • 1Department of Medicine, Program in Neuroscience, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA.

The Journal of Biological Chemistry
|January 6, 2005
PubMed

Insights

Neural RING finger protein 1 (Nrdp1) accelerates parkin degradation, reducing its activity. This finding impacts understanding of Parkinson disease pathogenesis and potential therapeutic targets.

Area of Science:

  • Molecular Biology
  • Neuroscience
  • Biochemistry

Background:

  • Parkin, a ubiquitin-protein ligase, is implicated in Parkinson disease pathogenesis due to its role in dopaminergic neuron survival.
  • Loss of parkin function may lead to substrate accumulation and neuronal death.

Purpose of the Study:

  • To identify proteins interacting with parkin.
  • To investigate the functional relationship between parkin and its interacting partners, specifically Nrdp1.
  • To elucidate the role of Nrdp1 in regulating parkin activity and substrate degradation.

Main Methods:

  • Yeast two-hybrid screen to identify interacting proteins.
  • In vitro binding assays, co-immunoprecipitation, and immunofluorescence for interaction validation.
  • Pulse-chase experiments to assess protein half-life.
  • Overexpression studies to analyze substrate degradation.

Main Results:

  • A novel RING finger protein, Nrdp1, was identified to interact with parkin.
  • Nrdp1, a ubiquitin-protein ligase, was shown to bind parkin and accelerate its degradation, reducing its half-life.
  • Nrdp1 reversed parkin-mediated degradation of its substrate, CDCrel-1.

Conclusions:

  • Nrdp1 acts as a parkin modifier by promoting parkin degradation.
  • This interaction reduces overall parkin activity, potentially influencing Parkinson disease progression.
  • Nrdp1 represents a novel regulatory mechanism for parkin function.

More Related Videos

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag08:55

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Protein Folding Quality Check in the RER01:29

Protein Folding Quality Check in the RER

ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...